Table 4. Receptor site affinity of available antiemetic drugs.
Drug group | Dopamine
(D2) |
Muscarinic
cholinergic |
Histamine
(H2) |
Serotonin
(5-HT3) |
NK-1
antagonist |
CB-1
modulator |
MOR
antagonist |
Gaba
mimetic |
---|---|---|---|---|---|---|---|---|
Antiserotonin | ||||||||
Ondansetron | - | - | - | ++++ | - | - | - | - |
Granisetron | - | - | - | ++++ | - | - | - | - |
Tropisetron | - | - | - | ++++ | - | - | - | - |
Palonosetron | - | - | - | ++++ | - | - | - | - |
Phenothiazines | ||||||||
Fluphenazine | ++++ | + | ++ | - | - | - | - | - |
Chlorpromazine | ++++ | ++ | ++++ | + | - | - | - | - |
Butyrophenones | ||||||||
Droperidol | ++++ | - | + | + | - | - | - | - |
Haloperidol | ++++ | - | + | - | - | - | - | - |
Domperidone | ++++ | - | - | - | - | - | - | - |
Antihistamines | ||||||||
Diphenhydramine | + | ++ | ++++ | - | - | - | - | - |
Promethazine | ++ | ++ | ++++ | - | - | - | - | - |
Anticholinergics | ||||||||
Scopolamine | + | ++++ | + | - | - | - | - | - |
Benzamides | ||||||||
Metoclopramide | +++ | - | + | ++ | - | - | - | - |
Tricyclic antidepressants | ||||||||
Amitriptyline | +++ | +++ | ++++ | - | - | - | - | - |
Nortriptyline | +++ | ++ | +++ | - | - | - | - | - |
Neurokinin-1 | ||||||||
Aprepitant | - | - | - | - | ++++ | - | - | - |
Fosaprepitant | - | - | - | - | ++++ | - | - | - |
Others | ||||||||
Dronabinol | - | - | - | - | - | ++++ | - | - |
Nabilone | - | - | - | - | - | +++ | - | - |
Naloxone | - | - | - | - | - | - | ++++ | |
Lorazepam | - | - | - | - | - | - | - | +++ |
The number of positive signs (+) indicates receptor activity.
This table was adapted with permission from White PF (ed). Ambulatory Anesthesia and Surgery. London, WB Saunders, 1997 Page 442 133